Mascoma Corporation

Granholm Says Mascoma Agreement Puts Michigan at Forefront of Next Generation Fuels

Granholm Says Mascoma Agreement Puts Michigan at Forefront of Next Generation Fuels

June 27, 2008

Historic investment set for production facility in U.P.’s Chippewa County

LANSING – Governor Jennifer M. Granholm and Mascoma Corporation CEO Bruce A. Jamerson today announced that the Massachusetts-based company has entered into a series of key strategic relationships to further Mascoma’s efforts to build its first commercial-scale cellulosic ethanol plant in Michigan’s Upper Peninsula.

Affinnova, Inc.

Powell Tops Democratic and Republican VP Candidates as Evolutionary Optimization Software Identifies Ideal 2008 Presidential Tickets

Powell Tops Democratic and Republican VP Candidates as Evolutionary Optimization Software Identifies Ideal 2008 Presidential Tickets

June 30, 2008

Surprise findings include Edwards, Clinton and Giuliani losing ground with likely voters due to polarizing appeal; economy is a top issue, Iraq War is not

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals Closes $33 Million Series A Funding

Agios Pharmaceuticals Closes $33 Million Series A Funding

July 7, 2008

Company Founded by Pioneers in Emerging Field of Cancer Metabolism

Accuri Cytometers, Inc.

Accuri Cytometers Completes $13 Million Series C Financing

Accuri Cytometers Completes $13 Million Series C Financing

July 8, 2008

New Funds will Support Expanded Commercialization of the Revolutionary Accuri C6 Flow Cytometer® System

BG Medicine, Inc.

BG Medicine Closes $40 Million in Series D Financing

BG Medicine Closes $40 Million in Series D Financing

July 17, 2008

Funds to accelerate launch of diagnostic products to enable Biomarker-Guided Medicine

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals Completes Series A Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform

Tetraphase Pharmaceuticals Completes Series A Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform

August 6, 2008

Raises $15M to Close Second Tranche of $25M Financing

WATERTOWN, Mass., Aug 06, 2008 (BUSINESS WIRE) -- Tetraphase Pharmaceuticals Inc. announced today that it has closed the second tranche of its $25 million Series A financing to support the advancement of several novel and potent antibiotic drug candidates. This second tranche of $15 million was funded by existing investors - Mediphase Venture Partners, CMEA Ventures, Fidelity Biosciences, Flagship Ventures and Skyline Ventures.

Affinnova, Inc.

Affinnova’s New Client Gains and Increasing Frequency Propel Sales Up 63%

Affinnova’s New Client Gains and Increasing Frequency Propel Sales Up 63%

August 11, 2008

Affinnova Announces First Half 2008 Results

Waltham, MA – August 11, 2008 – Affinnova, Inc., the global leader in optimization technology for innovation and marketing, today announced growth results for the first half ended June 30, 2008.

First Half Highlights

Affinnova grew sales for the first half ended June 30, 2008 by 63% compared to the first half of 2007, an increase of 25% compared to the second half of 2007.

Quanterix Corporation

Quanterix Corporation Raises $15 Million in Series A Financing

Quanterix Corporation Raises $15 Million in Series A Financing

August 26, 2008

Leader in single molecule detection will utilize funds to advance SiMoA™ technology

Novomer, Inc.

Novomer Recognized by AlwaysOn as GoingGreen Top 100 Winner

Novomer Recognized by AlwaysOn as GoingGreen Top 100 Winner

September 15, 2008

BOSTON - (Business Wire) Novomer Inc., a materials company pioneering a family of high-performance, biodegradable plastics, polymers and other chemicals from renewable substances, today announced that it has been honored by AlwaysOn as one of the GoingGreen Top 100 Winners. Novomer was selected by the AlwaysOn editorial team and other industry experts spanning the globe, based on a set of five criteria: innovation, market potential, commercialization, stakeholder value and media buzz.

AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals Initiates First Clinical Trial of Novel HGF Antagonist in Patients with Advanced Solid Tumors and Lymphomas

AVEO Pharmaceuticals Initiates First Clinical Trial of Novel HGF Antagonist in Patients with Advanced Solid Tumors and Lymphomas

September 23, 2008

SCH900105 (AV-299) Marks First of Several Monoclonal Antibodies from AVEO’s Discovery Platform; Trial Triggers Milestone Under Agreement with Schering Plough